Anika Therapeutics, Inc. (ANIK) vs CAMP4 Therapeutics Corporation (CAMP)

A side-by-side comparison of Anika Therapeutics, Inc. and CAMP4 Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIK vs CAMP

growth of $100 · dividends reinvested · last 2y
ANIK -22.7% (-12.1%/yr)CAMP -62.6% (-38.8%/yr)ANIK compounded faster over this window
20406080100Start $10020252026$77$37
ANIK CAMP

ANIK vs CAMP: by the numbers

  • •ANIK is the larger company ($256M vs $243M market cap).
  • •Both run net losses; ANIK's is the smaller (-3.14% vs -2543.74% net margin).
  • •Both shrank revenue over the past five years; ANIK's decline was smaller (-2.48% vs -57.68% CAGR).

Metrics side by side

Valuation

MetricANIKCAMP
Forward P/E18.21N/A
P/S ratio2.1257.53
P/B ratio1.86N/A
EV / EBITDA473.19N/A
FCF yield0.22%N/A

Profitability

MetricANIKCAMP
Gross margin62.16%53.14%
Operating margin-4.24%-1488.31%
Net margin-3.14%-2543.74%
ROE-2.76%N/A
ROIC-3.17%-69.76%

Growth (annualized)

MetricANIKCAMP
Revenue CAGR (5Y)-2.48%-57.68%
FCF CAGR (5Y)-39.38%N/A
Total return CAGR (5Y)-13.40%N/A

Frequently asked

Which has grown faster, ANIK or CAMP?
Neither grew: over the past five years both shrank revenue, with ANIK's decline the smaller — ANIK at a -2.48% CAGR versus CAMP at -57.68%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.